Lindbrook Capital, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Lindbrook Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$10.11 - $16.54 $960 - $1,571	95 Added 25.96%	461 $7,000
Q1 2023 Apr 26, 2023	SELL	$14.26 - $22.1 $1,468 - $2,276	-103 Reduced 21.96%	366 $5,000
Q4 2022 Jan 24, 2023	SELL	$14.85 - $19.04 $742 - $952	-50 Reduced 9.63%	469 $0
Q3 2022 Nov 10, 2022	BUY	$12.38 - $20.23 $619 - $1,011	50 Added 10.66%	519 $10,000
Q2 2022 Aug 01, 2022	BUY	$9.11 - $13.98 $2,978 - $4,571	327 Added 230.28%	469 $6,000
Q1 2022 Apr 21, 2022	BUY	$6.87 - $11.11 $975 - $1,577	142 New	142 $1,000
Q3 2021 Nov 05, 2021	SELL	$26.46 - $37.15 $2,804 - $3,937	-106 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$32.73 - $47.95 $3,240 - $4,747	99 Added 1414.29%	106 $4,000
Q2 2020 Jul 27, 2020	SELL	$37.05 - $65.03 $629 - $1,105	-17 Reduced 70.83%	7 $0
Q1 2020 Apr 22, 2020	BUY	$33.63 - $69.4 $807 - $1,665	24 New	24 $1,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.